(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 106.87%13.5M | 42.95%7.13M | 260.57%8.58M | 36.89%16.48M | -63.18%2.58M | 24.94%6.52M | 5,131.95%4.99M | 2,536.03%2.38M | 367.11%12.04M | 860.26%7.01M |
Net income from continuing operations | -6.78%6.67M | 264.75%1.25M | 6.25%3.18M | -419.35%-1.11M | -453.49%-10.49M | 250.31%7.15M | -198.58%-757.42K | 155.04%2.99M | -93.91%346.52K | -57.35%2.97M |
Operating gains losses | 50.05%-638.13K | -73.45%629.54K | 97.49%-35.88K | -114.68%-887.93K | -145.46%-554.05K | -122.86%-1.28M | 257.33%2.37M | -130.13%-1.43M | 1,011.51%6.05M | 262.03%1.22M |
Depreciation and amortization | 17.84%4.68M | -10.39%3.26M | 43.90%3.53M | 120.44%12.19M | 12.82%2.12M | 119.57%3.97M | 274.75%3.64M | 182.36%2.45M | 240.65%5.53M | 267.04%1.88M |
Asset impairment expenditure | --0 | ---- | ---- | 230.81%11.8M | --11.8M | --0 | ---- | ---- | -60.57%-9.02M | ---- |
Remuneration paid in stock | -3.39%144.05K | 94.85%309.85K | -23.41%101.28K | 80.49%591.45K | 33.73%151.09K | 34.48%149.1K | 288.64%159.02K | 110.17%132.24K | 220.29%327.69K | 110.48%112.98K |
Deferred tax | 5.19%-1.62M | 84.31%-348.77K | --459.87K | -152.20%-2.96M | -82.80%973.73K | ---1.71M | ---2.22M | --0 | 485.75%5.66M | 485.75%5.66M |
Other non cashItems | -107.91%-3.45K | -84.77%13.36K | -125.19%-23.08K | -39.73%363.04K | -16.32%140.06K | -77.06%43.6K | -48.31%87.74K | 21.90%91.64K | 7.67%602.34K | 284.52%167.36K |
Change In working capital | 296.65%4.26M | -72.05%478.67K | 173.73%1.37M | -238.17%-3.51M | -129.80%-1.2M | -231.95%-2.17M | 163.14%1.71M | -353.03%-1.86M | 158.32%2.54M | 875.00%4.02M |
-Change in receivables | 262.67%2.38M | 40.20%-480.34K | -87.71%135.48K | -141.50%-4.86M | -305.31%-3.69M | -26.55%-1.46M | 63.17%-803.26K | 333.23%1.1M | -172.92%-2.01M | 46.57%1.8M |
-Change in inventory | 54.91%-4.07K | 940.68%445.69K | 100.08%92 | 146.52%213.35K | 1,034,797.37%393.19K | 96.07%-9.03K | 64.76%-53.02K | -50.41%-117.8K | -110.61%-458.61K | -100.03%-38 |
-Change in prepaid assets | 17.02%79.7K | -51.33%37.99K | -34.64%-152.96K | -124.23%-39.94K | -1,743.34%-72.5K | -60.31%68.11K | -4.22%78.06K | -22.57%-113.61K | 167.30%164.84K | 103.88%4.41K |
-Change in payables and accrued expense | 317.92%1.81M | -84.83%391.56K | 138.44%1.05M | -75.58%1.2M | -11.07%2.17M | -132.35%-829.58K | 945.19%2.58M | -1,266.62%-2.72M | 171.32%4.93M | 237.96%2.44M |
-Change in other working capital | -101.40%-921 | 192.24%83.77K | 2,902.43%343.75K | 58.19%-36.05K | 100.52%1.14K | -77.42%65.89K | ---90.81K | ---12.27K | -132.85%-86.23K | ---220.59K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 106.87%13.5M | 42.95%7.13M | 260.57%8.58M | 36.89%16.48M | -63.18%2.58M | 24.94%6.52M | 5,131.95%4.99M | 2,536.03%2.38M | 367.11%12.04M | 860.26%7.01M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -48.95%-8.45M | -41.40%-7.24M | -110.88%-9.03M | -169.37%-22.58M | -113.72%-7.51M | -330.13%-5.67M | -219.91%-5.12M | -119.49%-4.28M | -107.18%-8.38M | -113.89%-3.51M |
Net PPE purchase and sale | -26.94%-6.95M | -30.50%-8.97M | -47.05%-6.28M | -253.18%-27.08M | -397.11%-10.47M | -165.71%-5.47M | -147.34%-6.87M | -488.66%-4.27M | -348.07%-7.67M | -42.23%-2.11M |
Net other investing changes | -644.91%-1.51M | -1.37%1.73M | -22,994.95%-2.75M | 729.19%4.5M | 310.50%2.96M | -127.30%-202.07K | 48.76%1.75M | 99.03%-11.92K | 69.37%-715.22K | -770.31%-1.41M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -48.95%-8.45M | -41.40%-7.24M | -110.88%-9.03M | -169.37%-22.58M | -113.72%-7.51M | -330.13%-5.67M | -219.91%-5.12M | -119.49%-4.28M | -107.18%-8.38M | -113.89%-3.51M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.52%5.86K | 97.52%-34.78K | -101.80%-20.49K | 473.91%5.39M | 365.93%4.43M | 850.96%1.22M | -1,483.52%-1.4M | 42,229.81%1.14M | -117.79%-1.44M | -120.55%-1.67M |
Net issuance payments of debt | 118.56%5.86K | 98.29%-34.78K | -76.82%-20.49K | -7.24%-2.09M | 98.98%-19.4K | 6.16%-31.55K | -19,500.79%-2.03M | -26.13%-11.59K | 37.77%-1.95M | 39.11%-1.9M |
Net common stock issuance | --0 | --0 | --0 | 1,364.37%7.48M | 1,830.63%4.45M | 672.85%1.25M | 461.13%627.18K | 17,588.81%1.15M | -95.45%510.79K | -97.95%230.71K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.52%5.86K | 97.52%-34.78K | -101.80%-20.49K | 473.91%5.39M | 365.93%4.43M | 850.96%1.22M | -1,483.52%-1.4M | 42,229.81%1.14M | -117.79%-1.44M | -120.55%-1.67M |
Net cash flow | ||||||||||
Beginning cash position | 0.23%10.83M | -6.06%11.61M | -7.09%12.14M | 20.06%13.06M | 13.31%12.89M | 46.60%10.8M | 37.77%12.35M | 20.06%13.06M | -5.18%10.88M | 108.14%11.38M |
Current changes in cash | 144.09%5.05M | 90.99%-137.85K | 38.54%-471.52K | -132.61%-721.3K | -126.92%-492.87K | -48.67%2.07M | 4.21%-1.53M | 62.61%-767.17K | 584.33%2.21M | -67.01%1.83M |
Effect of exchange rate changes | 3,105.92%659.87K | -2,747.13%-642.11K | -194.86%-57.51K | -600.87%-204.29K | -79.61%-262.95K | 192.82%20.58K | -1,675.83%-22.55K | -56.91%60.63K | 78.89%-29.15K | -6.74%-146.4K |
End cash Position | 28.28%16.54M | 0.23%10.83M | -6.06%11.61M | -7.09%12.14M | -7.09%12.14M | 13.31%12.89M | 46.60%10.8M | 37.77%12.35M | 20.06%13.06M | 20.06%13.06M |
Free cash from | 522.51%6.55M | 2.57%-1.83M | 221.65%2.3M | -342.89%-10.61M | -260.84%-7.89M | -66.73%1.05M | 34.67%-1.88M | -129.73%-1.89M | 170.24%4.37M | 304.11%4.91M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data